CTL Medical received FDA 510(k) clearance to support the MATISSE™ Ti-PEEK ACIF cage, featuring TiCro™ surface technology.
The first version of MATISSE received 510(k) clearance in 2012, under Accel Spine. CTL acquired Accel in early 2016 and gained a next FDA clearance for MATISSE in mid-2017.
Updates to MATISSE include three material options. As with previous models, MATISSE is available in a variety of sizes and profiles. Like the original titanium-based version, the Ti-PEEK interbody is designed to support a 200% greater endplate contact surface area. The device is indicated for use with supplemental fixation, such as the company’s VAN GOGH™ Anterior cervical plate.
CTL Medical received FDA 510(k) clearance to support the MATISSE™ Ti-PEEK ACIF cage, featuring TiCro™ surface technology.
The first version of MATISSE received 510(k) clearance in 2012, under Accel Spine. CTL acquired Accel in early 2016 and gained a next FDA clearance for MATISSE in mid-2017.
Updates to MATISSE include three material...
CTL Medical received FDA 510(k) clearance to support the MATISSE™ Ti-PEEK ACIF cage, featuring TiCro™ surface technology.
The first version of MATISSE received 510(k) clearance in 2012, under Accel Spine. CTL acquired Accel in early 2016 and gained a next FDA clearance for MATISSE in mid-2017.
Updates to MATISSE include three material options. As with previous models, MATISSE is available in a variety of sizes and profiles. Like the original titanium-based version, the Ti-PEEK interbody is designed to support a 200% greater endplate contact surface area. The device is indicated for use with supplemental fixation, such as the company’s VAN GOGH™ Anterior cervical plate.
Copy to clipboard 
